Amela Hozić Zimmermann

Amela Hozić Zimmermann

Auto-generated profile, based on publicly available information

Amela Hozić Zimmermann

Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička 54, 10000 Zagreb, Croatia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2011 in Marine Drugs
Verified
Journal Article
Open access
PDF file
VSVesna Svetlicic
Vesna Svetlicic
VZVera Zutic
Vera Zutic
TRTea Mišić Radić
Tea Mišić Radić
PGPletikapić Galja
Pletikapić Galja
AZAmela Hozić Zimmermann
Amela Hozić Zimmermann
RURanieri Urbani
Ranieri Urbani
Using high resolution molecular technique of atomic force microscopy, we address the extracellular polymer production of Adriatic diatom Cylindrotheca closterium analyzed at the single cell level and the supramolecular organization of gel phase isolated from the Northern Adriatic macroaggregates. Our results revealed that extracellular polysaccharides freshly produced by marine diatoms can self-assemble directly to form gel network characteristics of the macroscopic gel phase in the natural aquatorium. Based on the experiments performed with isolated polysaccharide fractions of C. closterium and of macroaggregates gel phase, we demonstrated that the polysaccharide self-assembly into gel network can proceed independent of any bacterial mediation or interaction with inorganic particles.

13 November 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LDLucija Dončević
Lucija Dončević
ESEma Svetlicic
Ema Svetlicic
AHAmela Hozić
Amela Hozić
BMBranka Mihaljevic
Branka Mihaljevic
DJDorota Jarmużek
Dorota Jarmużek
MCMario Cindric
Mario Cindric
Rosuvastatin, a member of the statin family of drugs, is used to regulate high cholesterol levels in the human body. Moreover, rosuvastatin and other statins demonstrate a protective role against free radical-induced oxidative stress. Our research aimed to investigate the end-products of free radical-induced degradation of rosuvastatin. To induce the radical degradation, an aqueous solution of rosuvastatin was irradiated using different doses of gamma radiation (50–1000 Gy) under oxidative conditions. Rosuvastatin and related degradation products were separated on nanoC18 column under gradient elution, and identification was carried out on hyphenated nanoUPLC and nanoESI-QTOF mass spectrometer system. Elemental composition analysis using highly accurate mass measurements together with isotope fitting algorithm identified nine major degradation products. This is the first study of gamma radiation-induced degradation of rosuvastatin, where chemical structures, MS/MS fragmentation pathways and formation mechanisms of the resulting degradation products are detailly described. The presented results contribute to the understanding of the degradation pathway of rosuvastatin and possibly other statins under gamma radiation conditions.